🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
4,720 results for “eu”
MedicineActive substanceLicence holderStatus
AYVAKYT 100 mg film-coated tablets
EU/1/20/1473/001
Avapritinib Blueprint Medicines (Netherlands) B.V.
AYVAKYT 200 mg film-coated tablets
EU/1/20/1473/002
Avapritinib Blueprint Medicines (Netherlands) B.V.
AYVAKYT 25 mg film-coated tablets
EU/1/20/1473/004
Avapritinib Blueprint Medicines (Netherlands) B.V.
AYVAKYT 300 mg film-coated tablets
EU/1/20/1473/003
Avapritinib Blueprint Medicines (Netherlands) B.V.
AYVAKYT 50 mg film-coated tablets
EU/1/20/1473/005
Avapritinib Blueprint Medicines (Netherlands) B.V.
Azacitidine Accord 200 mg film-coated tablets
EU/1/19/1413/003-010
Azacitidine Accord Healthcare S.L.U.
Azacitidine Accord 25 mg/mL powder for suspension for injection
EU/1/19/1413/001
Azacitidine Accord Healthcare S.L.U.
Azacitidine Accord 25 mg/mL powder for suspension for injection
EU/1/19/1413/002
Azacitidine Accord Healthcare S.L.U.
Azacitidine Accord 300 mg film-coated tablets
EU/1/19/1413/011-018
Azacitidine Accord Healthcare S.L.U.
Azacitidine betapharm 25 mg/mL powder for suspension for injection
EU/1/19/1416/001
Azacitidine Betapharm Arzneimittel GmbH
Azacitidine Kabi 25 mg/mL powder for suspension for injection
EU/1/23/1777/001
Azacitidine Fresenius Kabi Deutschland GmbH
Azacitidine Mylan 25 mg/mL powder for suspension for injection
EU/1/20/1426/001-002
Azacitidine Mylan Pharmaceuticals Limited
Azacitidine Seacross 25 mg/ml powder for suspension for injection
PA22766/005/001
Azacitidine Seacross Pharma (Europe) Limited Marketed
Azactam 1 g Powder for Solution for Injection or Infusion
PA1418/021/001
Aztreonam Athlone Pharmaceuticals Limited Marketed
Azactam 2 g Powder for Solution for Injection or Infusion
PA1418/021/002
Aztreonam Athlone Pharmaceuticals Limited Marketed
Azarga 10 mg/ml + 5 mg/ml eye drops, suspension
EU/1/08/482/1-2
Timolol Maleate, Brinzolamide Novartis Europharm Limited
AZILECT 1 mg tablets
EU/1/04/304/1-7
Rasagiline Teva B.V.
Azomyr 0.5 mg/ml oral solution
EU/1/00/157/59-67
Desloratadine N.V. Organon
Azomyr 5 mg film-coated tablets
EU/1/00/157/001-013
Desloratadine N.V. Organon
Azopt 10 mg/ml eye drops, suspension
EU/1/00/129/001
Brinzolamide Novartis Europharm Limited
Azopt 10 mg/ml eye drops, suspension
EU/1/00/129/002
Brinzolamide Novartis Europharm Limited
Azuzote 30 mg film-coated tablets
PA22871/001/001
Nefopam hydrochloride Azure Pharmaceuticals Ltd. Marketed
Baiama 40 mg/mL solution for injection in a vial
EU/1/24/1887/001
Aflibercept Formycon AG
Balversa 3 mg Film-coated tablet
EU/1/24/1841/001-004
Erdafitinib Janssen-Cilag International NV
Balversa 4 mg Film-coated tablet
EU/1/24/1841/005-009
Erdafitinib Janssen-Cilag International NV
Balversa 5 mg Film-coated tablet
EU/1/24/1841/010-011
Erdafitinib Janssen-Cilag International NV
Baqsimi 3 mg nasal powder in single-dose container
EU/1/19/1406/001-002
GLUCAGON Amphastar France Pharmaceuticals, S.A.S.
Baraclude
EU/1//06/343/01
Entecavir Bristol-Myers Squibb Pharma EEIG
Baraclude 0.05 mg/ml oral solution
EU/1/06/343/05
Entecavir Bristol-Myers Squibb Pharma EEIG
Baraclude 0.5 mg film-coated tablets
EU/1/06/343/001,3,6
Entecavir Bristol-Myers Squibb Pharma EEIG
Baraclude 1 mg film-coated tablets
EU/1/06/343/02,04,07
Entecavir Bristol-Myers Squibb Pharma EEIG
Bavencio 20 mg/mL concentrate for solution for infusion
EU/1/17/1214/001
Avelumab Merck Europe B.V.
Becloneb 400 micrograms/1 ml nebuliser suspension
PA0584/003/001
Beclometasone dipropionate Chiesi Farmaceutici S.p.A. Not marketed
Becloneb 800 micrograms/2 ml nebuliser suspension
PA0584/003/002
Beclometasone dipropionate Chiesi Farmaceutici S.p.A. Not marketed
Beclospin 400 micrograms/1 ml nebuliser suspension
PA0584/004/001
Beclometasone dipropionate anhydrous Chiesi Farmaceutici S.p.A. Not marketed
Beclospin 800 micrograms/2 ml nebuliser suspension
PA0584/004/002
Beclometasone dipropionate Chiesi Farmaceutici S.p.A. Not marketed
BEKEMV 300 mg Concentrate for solution for infusion
EU/1/23/1727/001
Eculizumab Amgen Technology (Ireland) Unlimited Company
Bemfola
EU/1/13/909/001-005
Follitropin alfa Gedeon Richter Plc
Bemrist Breezhaler 125 micrograms/127.5 micrograms inhalation powder, hard capsules
EU/1/20/1441/005-008
Indacaterol acetate, Indacaterol, Mometasone furoate Novartis Europharm Limited
Bemrist Breezhaler 125 micrograms/260 micrograms inhalation powder, hard capsules
EU/1/20/1441/009-012
Indacaterol acetate, Indacaterol, Mometasone furoate Novartis Europharm Limited
Bemrist Breezhaler 125 micrograms/62.5 micrograms inhalation powder, hard capsules
EU/1/20/1441/001-004
Indacaterol acetate, Indacaterol, Mometasone furoate Novartis Europharm Limited
Bendamustine HCl 100 mg Powder for Concentrate for Solution for Infusion
PA2059/028/002
Bendamustine hydrochloride Fresenius Kabi Deutschland GmbH Marketed
Bendamustine HCl 25 mg Powder for Concentrate for Solution for Infusion
PA2059/028/001
Bendamustine hydrochloride Fresenius Kabi Deutschland GmbH Marketed
BeneFIX 1000 IU powder and solvent for solution for injection
EU/1/97/047/006
Nonacog alfa Pfizer Europe MA EEIG
BeneFIX 1500 IU powder and solvent for solution for injection
EU/1/97/047/009
Nonacog alfa Pfizer Europe MA EEIG
BeneFIX 2000 IU powder and solvent for solution for injection
EU/1/97/047/007
Nonacog alfa Pfizer Europe MA EEIG
BeneFIX 250 IU powder and solvent for solution for injection
EU/1/97/047/004
Nonacog alfa Pfizer Europe MA EEIG
BeneFIX 3000 IU powder and solvent for solution for injection
EU/1/97/047/008
Nonacog alfa Pfizer Europe MA EEIG
BeneFIX 500 IU powder and solvent for solution for injection
EU/1/97/047/005
Nonacog alfa Pfizer Europe MA EEIG
Benepali 25 mg solution for injection in pre-filled syringe
EU/1/15/1074/005-007
Etanercept Samsung Bioepis NL B.V.
6 7 8 9 10 11 12
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.